Jim Simons’s Globus Medical GMED Stock Holding History

Jim Simons’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-243,918	Closed	-$14M	–	3426
2025 Q3	$14M	Buy	243,918 +138,500	+131%	+$7.98M	0.02%	908
2025 Q2	$6.22M	Sell	105,418 -71,500	-40%	-$4.62M	0.01%	1382
2025 Q1	$13M	Buy	+176,918	New	+$14.6M	0.02%	869
2023 Q4	–	Sell	-158,518	Closed	-$7.87M	–	3861
2023 Q3	$7.87M	Buy	+158,518	New	+$8.86M	0.01%	1060
2022 Q3	–	Sell	-54,700	Closed	-$3.07M	–	4159
2022 Q2	$3.07M	Sell	54,700 -10,100	-16%	-$664K	﹤0.01%	1894
2022 Q1	$4.78M	Buy	64,800 +17,700	+38%	+$1.23M	0.01%	1622
2021 Q4	$3.4M	Sell	47,100 -133,546	-74%	-$9.69M	﹤0.01%	1778
2021 Q3	$13.8M	Buy	180,646 +37,546	+26%	+$3.01M	0.02%	853
2021 Q2	$11.1M	Sell	143,100 -25,600	-15%	-$1.82M	0.01%	1102
2021 Q1	$10.4M	Buy	168,700 +39,200	+30%	+$2.48M	0.01%	1166
2020 Q4	$8.45M	Sell	129,500 -14,014	-10%	-$806K	0.01%	1274
2020 Q3	$7.11M	Sell	143,514 -566,800	-80%	-$29.2M	0.01%	1359
2020 Q2	$33.9M	Sell	710,314 -634,400	-47%	-$30.6M	0.03%	562
2020 Q1	$57.2M	Buy	1,344,714 +266,700	+25%	+$13.2M	0.06%	350
2019 Q4	$63.5M	Sell	1,078,014 -167,386	-13%	-$9.09M	0.05%	428
2019 Q3	$63.7M	Sell	1,245,400 -19,200	-2%	-$914K	0.05%	416
2019 Q2	$53.5M	Sell	1,264,600 -95,200	-7%	-$4.13M	0.05%	464
2019 Q1	$67.2M	Buy	1,359,800 +137,400	+11%	+$6.22M	0.06%	389
2018 Q4	$52.9M	Buy	1,222,400 +331,965	+37%	+$16.6M	0.06%	401
2018 Q3	$50.5M	Buy	890,435 +35,535	+4%	+$1.87M	0.05%	428
2018 Q2	$43.1M	Buy	854,900 +351,100	+70%	+$18.3M	0.05%	504
2018 Q1	$25.1M	Buy	503,800 +82,600	+20%	+$3.88M	0.03%	801
2017 Q4	$17.3M	Sell	421,200 -258,100	-38%	-$9.04M	0.02%	1043
2017 Q3	$20.2M	Buy	679,300 +608,900	+865%	+$18.6M	0.02%	894
2017 Q2	$2.33M	Buy	+70,400	New	+$2.21M	﹤0.01%	2171
2016 Q3	–	Sell	-104,700	Closed	-$2.5M	–	3387
2016 Q2	$2.5M	Sell	104,700 -242,000	-70%	-$5.8M	﹤0.01%	2072
2016 Q1	$8.23M	Buy	+346,700	New	+$8.48M	0.02%	1271
2015 Q4	–	Sell	-143,945	Closed	-$2.97M	–	3323
2015 Q3	$2.97M	Buy	+143,945	New	+$3.65M	0.01%	1736
2015 Q2	–	Sell	-98,300	Closed	-$2.48M	–	3276
2015 Q1	$2.48M	Sell	98,300 -151,800	-61%	-$3.7M	0.01%	1813
2014 Q4	$5.95M	Sell	250,100 -602,400	-71%	-$13.3M	0.01%	1174
2014 Q3	$16.8M	Buy	852,500 +66,100	+8%	+$1.36M	0.05%	518
2014 Q2	$18.8M	Buy	786,400 +605,287	+334%	+$14.6M	0.04%	509
2014 Q1	$4.82M	Sell	181,113 -92,487	-34%	-$2.2M	0.01%	1274
2013 Q4	$5.52M	Buy	+273,600	New	+$5.08M	0.01%	1128

Other funds holding GMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.5% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Jim Simons's GMED Position: Q4 2025 in Review

Jim Simons sold out of Globus Medical (GMED) in Q4 2025, closing a stake of 243,918 shares — an estimated $14M sold.

Jim Simons first reported a position in GMED in Q4 2013 and held it in 34 quarters. The position peaked at $67.2M in Q1 2019. 563 funds tracked by Wall St. Rank hold GMED as of Q4 2025.

Jim Simons reported no remaining Globus Medical position as of Q4 2025 after selling out during the quarter.
Jim Simons sold 243,918 Globus Medical shares in Q4 2025, an estimated $14M.
Jim Simons first reported a position in Globus Medical in Q4 2013 and held it in 34 quarters.
Jim Simons's Globus Medical position peaked at $67.2M in Q1 2019.
563 funds tracked by Wall St. Rank held Globus Medical as of Q4 2025.

Based on Renaissance Technologies's 13F filing for Q4 2025, filed 12 Feb 2026.